• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受大剂量治疗的多发性骨髓瘤患者外周血干细胞移植中的骨髓瘤细胞污染

Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy.

作者信息

Mariette X, Fermand J P, Brouet J C

机构信息

Laboratory of Immunopathology, Hôpital Saint-Louis, Paris, France.

出版信息

Bone Marrow Transplant. 1994 Jul;14(1):47-50.

PMID:7524906
Abstract

In order to assess the contamination with malignant cells of peripheral blood stem cell (PBSC) transplants used to support high-dose therapy in multiple myeloma (MM), we used the immunoglobulin heavy chain gene radioactive fingerprinting polymerase chain reaction (PCR) method to detect clonal cells in PBSC from 10 patients. The sensitivity of the technique allowed the detection of one clonal cell among 10(4) normal blood mononuclear cells. A clonal band was detected in 4 of 11 leukaphereses samples. The level of contamination was low because a clonal band could never be identified on ethidium bromide-stained agarose gels whose sensitivity is between 1 and 5%. The use of granulocyte-colony stimulatory factor (G-CSF) in combination with chemotherapy in three cases did not seem to increase the contamination of PBSC grafts; in one patient, G-CSF was used during a second course of leukapheresis which was free of detectable clonal cells whereas the first one performed after chemotherapy alone contained clonal cells. Thus, PBSC grafts may rarely be completely devoid of clonal potentially malignant cells but the level of contamination is much lower than in BM grafts. Whether graft contamination is an important adverse prognostic factor for patients with MM undergoing intensive treatment and autografting is still unsettled.

摘要

为了评估用于支持多发性骨髓瘤(MM)高剂量治疗的外周血干细胞(PBSC)移植中恶性细胞的污染情况,我们采用免疫球蛋白重链基因放射性指纹聚合酶链反应(PCR)方法检测了10例患者PBSC中的克隆细胞。该技术的灵敏度能够检测出10⁴个正常血液单核细胞中的一个克隆细胞。在11个白细胞分离样本中的4个检测到了克隆条带。污染水平较低,因为在灵敏度为1%至5%的溴化乙锭染色琼脂糖凝胶上从未鉴定出克隆条带。在3例患者中,粒细胞集落刺激因子(G-CSF)与化疗联合使用似乎并未增加PBSC移植物的污染;在1例患者中,第二次白细胞分离过程中使用了G-CSF,未检测到克隆细胞,而仅在化疗后进行的第一次白细胞分离中含有克隆细胞。因此,PBSC移植物可能很少完全没有克隆性潜在恶性细胞,但污染水平远低于骨髓移植物。对于接受强化治疗和自体移植的MM患者,移植物污染是否是一个重要的不良预后因素仍未确定。

相似文献

1
Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy.接受大剂量治疗的多发性骨髓瘤患者外周血干细胞移植中的骨髓瘤细胞污染
Bone Marrow Transplant. 1994 Jul;14(1):47-50.
2
Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.多发性骨髓瘤自体干细胞移植后基因标记的CD34+细胞的长期随访
Cancer Gene Ther. 2007 Mar;14(3):227-32. doi: 10.1038/sj.cgt.7701006. Epub 2006 Nov 3.
3
Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.粒细胞集落刺激因子与粒细胞巨噬细胞集落刺激因子联合强化化疗用于多发性骨髓瘤外周血干细胞动员和自体移植的随机对照研究
Biol Blood Marrow Transplant. 2004 Jun;10(6):395-404. doi: 10.1016/j.bbmt.2004.02.001.
4
Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.对VDJH扩增片段进行基因扫描是一种具有临床相关性的技术,用于检测接受自体外周血干细胞移植的多发性骨髓瘤患者单采血液成分制品中污染的肿瘤细胞。
Bone Marrow Transplant. 2001 Oct;28(7):665-72. doi: 10.1038/sj.bmt.1703219.
5
Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.采用低剂量环磷酰胺加粒细胞集落刺激因子采集外周血祖细胞用于自体移植。
Haematologica. 1998 May;83(5):428-31.
6
Natural killer cell numbers and activity in mobilized peripheral blood stem cell grafts: conditions for in vitro expansion.动员外周血干细胞移植物中自然杀伤细胞的数量和活性:体外扩增的条件
Exp Hematol. 1995 Dec;23(14):1676-81.
7
CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma.在多发性骨髓瘤患者接受多轮高剂量治疗及动员后,采用CD34+选择法获取自体外周血干细胞用于移植。
Bone Marrow Transplant. 2000 Jun;25(11):1175-84. doi: 10.1038/sj.bmt.1702408.
8
Leukapheresis products in multiple myeloma: lower tumor load after mobilization with cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) compared with G-CSF alone.多发性骨髓瘤中的白细胞分离术产品:与单独使用粒细胞集落刺激因子(G-CSF)相比,环磷酰胺联合G-CSF动员后肿瘤负荷更低。
Exp Hematol. 1998 Sep;26(10):969-75.
9
Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma.多发性骨髓瘤患者化疗后外周血干细胞采集中恶性B细胞的检测
Bone Marrow Transplant. 1995 May;15(5):707-11.
10
Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts.骨髓采集物和白细胞单采自体移植物中多发性骨髓瘤肿瘤污染的定量比较。
Bone Marrow Transplant. 1996 Jul;18(1):103-10.

引用本文的文献

1
Assessment of tumoral plasma cells in apheresis products for autologous stem cell transplantation in multiple myeloma.多发性骨髓瘤自体干细胞移植中采集产物肿瘤浆细胞的评估
Bone Marrow Transplant. 2016 Aug;51(8):1143-5. doi: 10.1038/bmt.2016.74. Epub 2016 Apr 4.
2
Comparison of twin and autologous transplants for multiple myeloma.多发性骨髓瘤双胞胎移植与自体移植的比较。
Biol Blood Marrow Transplant. 2008 Oct;14(10):1118-1124. doi: 10.1016/j.bbmt.2008.07.007.
3
Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation.
外周血干细胞移植物中的骨髓瘤细胞污染可预测多发性骨髓瘤患者在大剂量化疗和自体干细胞移植后的预后。
J Cancer Res Clin Oncol. 2005 Apr;131(4):214-8. doi: 10.1007/s00432-004-0635-y. Epub 2004 Dec 23.
4
Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma.用于既往未经治疗的多发性骨髓瘤自体移植的骨髓与血源干细胞的比较。
Br J Cancer. 1997;75(11):1684-9. doi: 10.1038/bjc.1997.286.
5
Detection of minimal residual disease in multiple myeloma and acute leukaemia.多发性骨髓瘤和急性白血病微小残留病的检测
Med Oncol. 1996 Jun;13(2):121-31. doi: 10.1007/BF02993863.
6
Multiple myeloma, high-dose treatment and autologous stem cell transplantation--current status.多发性骨髓瘤、大剂量治疗及自体干细胞移植——现状
Med Oncol. 1996 Mar;13(1):23-30. doi: 10.1007/BF02988838.